Gene · 2101
Papers2,737
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
461 to 480 of 2,737
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Osteoarthritis animal models for biomaterial-assisted osteochondral regeneration. | Biomater Transl | 2022 | 36846505 | PubTator, text mining | PubMed |
| Racial disparities in the genetic landscape of lung cancer. | Cancer Health Disparities | 2022 | 36819657 | PubTator, text mining | PubMed |
| CpH methylome analysis in human cortical neurons identifies novel gene pathways and drug targets for opioid use disorder. | Front Psychiatry | 2022 | 36745154 | PubTator, text mining | PubMed |
| Differential expression of nuclear hormone receptors by dendritic cell subsets in human vaginal mucosa and skin. | Front Immunol | 2022 | 36713394 | PubTator, text mining | PubMed |
| Lysine specific demethylase 1 is a molecular driver and therapeutic target in sarcoma. | Front Oncol | 2022 | 36686841 | PubTator, text mining | PubMed |
| A Guide to In Silico Drug Design. | Pharmaceutics | 2022 | 36678678 | PubTator, text mining | PubMed |
| LSD1 for the Targeted Regulation of Adipose Tissue. | Curr Issues Mol Biol | 2022 | 36661498 | PubTator, text mining | PubMed |
| De novo cholesterol biosynthesis: an additional therapeutic target for the treatment of postmenopausal breast cancer with excessive adipose tissue. | Explor Target Antitumor Ther | 2022 | 36654818 | PubTator, text mining | PubMed |
| Manipulating T-cell metabolism to enhance immunotherapy in solid tumor. | Front Immunol | 2022 | 36618408 | PubTator, text mining | PubMed |
| NAD Supplement Alleviates Intestinal Barrier Injury Induced by Ethanol Via Protecting Epithelial Mitochondrial Function. | Nutrients | 2022 | 36615829 | PubTator, text mining | PubMed |
| FAT/CD36 Participation in Human Skeletal Muscle Lipid Metabolism: A Systematic Review. | J Clin Med | 2022 | 36615118 | PubTator, text mining | PubMed |
| An Inverse Agonist GSK5182 Increases Protein Stability of the Orphan Nuclear Receptor ERRγ via Inhibition of Ubiquitination. | Int J Mol Sci | 2022 | 36613556 | PubTator, text mining | PubMed |
| Hormone-Dependent Cancers: Molecular Mechanisms and Therapeutical Implications. | Cells | 2022 | 36611904 | PubTator, text mining | PubMed |
| The mechanism study of Miao medicine Tongfengting decoction in the treatment of gout based on network pharmacology and molecular docking. | Medicine (Baltimore) | 2022 | 36595750 | PubTator, text mining | PubMed |
| Bioinformatic Analysis of Genetic Factors from Human Blood Samples and Postmortem Brains in Parkinson's Disease. | Oxid Med Cell Longev | 2022 | 36593912 | PubTator, text mining | PubMed |
| Mitochondrial dysfunction in pulmonary arterial hypertension. | Front Physiol | 2022 | 36589421 | PubTator, text mining | PubMed |
| Association between PPARγ, PPARGC1A, and PPARGC1B genetic variants and susceptibility of gastric cancer in an Eastern Chinese population. | BMC Med Genomics | 2022 | 36587194 | PubTator, text mining | PubMed |
Genome-wide distribution of histone trimethylation reveals a global impact of bisphenol A on telomeric binding proteins and histone acetyltransferase factors: a pilot study with human and in vitro data. | Clin Epigenetics | 2022 | 36572933 | PubTator, text mining | PubMed |
| The molecular basis of the dichotomous functionality of MAP4K4 in proliferation and cell motility control in cancer. | Front Oncol | 2022 | 36568222 | PubTator, text mining | PubMed |
| Design, Synthesis and In Vitro Investigation of Cabozantinib-Based PROTACs to Target c-Met Kinase. | Pharmaceutics | 2022 | 36559322 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2101/papers?page=24